Efficacy of calcitriol to bone resorption and PTH level: clinical study.

dc.contributor.authorBunyaratavej, Nen_US
dc.contributor.authorKitimanon, Nen_US
dc.contributor.authorTunjariyanond, Ken_US
dc.date.accessioned2009-05-27T20:01:50Z
dc.date.available2009-05-27T20:01:50Z
dc.date.issued2001-10-21en_US
dc.descriptionChotmaihet Thangphaet.en_US
dc.description.abstractStudy of the effect of calcitriol (Rocaltrol) to bone markers and PTH level in 146 menopausal women. The result showed a dose of calcitriol 0.75 microgram/day for one month significantly decreased the level of PTH, bone marker for resorption and NMID osteocalcin 61.55, 69.92, 60.02 per cent respectively (p=0.000). The other group which took calcitriol 0.5 microgram/day had little change to such markers. The active form of vitamin D benefits bone health by enhancing osteocalcin formation, in addition vitamin D has moderate antiresorption and suppression of PTH secretion.en_US
dc.description.affiliationDepartment of Orthopaedic Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.en_US
dc.identifier.citationBunyaratavej N, Kitimanon N, Tunjariyanond K. Efficacy of calcitriol to bone resorption and PTH level: clinical study. Journal of the Medical Association of Thailand. 2001 Oct; 84 Suppl 2(): S582-5en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/42241
dc.language.isoengen_US
dc.source.urihttps://www.mat.or.th/journal/all.phpen_US
dc.subject.meshBiological Markers --blooden_US
dc.subject.meshBone Resorption --diagnosisen_US
dc.subject.meshCalcitriol --therapeutic useen_US
dc.subject.meshFemaleen_US
dc.subject.meshHumansen_US
dc.subject.meshMenopause --blooden_US
dc.subject.meshOsteocalcin --blooden_US
dc.subject.meshParathyroid Hormone --blooden_US
dc.titleEfficacy of calcitriol to bone resorption and PTH level: clinical study.en_US
dc.typeJournal Articleen_US
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description: